Daron Evans Net Worth & Insider Trades
Daron Evans - CEO Specialty Renal Product, Nephros Inc
What is Daron Evans's Net Worth?
The current estimated net worth of Nephros Inc's CEO Specialty Renal Product, Daron Evans, is estimated to be about $67.65K . Daron Evans owns about 140,326 units of Nephros Inc common stock. In the last 7 years at Nephros Inc, Daron Evans has sold an estimated value of $0 worth.
What is Daron Evans's Past Insider Trading?
Daron Evans's largest purchase order was 79,000 units , worth over $35.55K on April 12, 2018. In total, Daron Evans has made about 35 transactions over 7 years of their time at Nephros Inc. Daron Evans usually trades in December, with the busiest year in 2017. The most recent transaction was a purchase order of 2,500 units , worth over $16.63K on March 12, 2020.
Daron Evans
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Daron Evans's Salary in 2020?
As CEO Specialty Renal Product of Nephros Inc, Daron Evans has a total base salary of $300,177 . Daron Evans received compensation valued at about $300.177 in 2020 after becoming CEO Specialty Renal Product. The vast majority of their compensation came in the form of
What is Daron Evans's' Mailing Address?
- Mailing address is C/o Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 NJ
Nephros Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Andrew Astor | 2020 | $309,006 | - | - | $680,547 | - | $989,553 |
| Andrew Astor | 2019 | $295,108 | $51,644 | $58,687 | $114,689 | $8,853 | $528,981 |
| Daron Evans | 2020 | $300,177 | - | - | - | - | $300.177 |
| Daron Evans | 2019 | $350,000 | $70,000 | $79,547 | $114,689 | $10,500 | $624,736 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1196298/000149315221008202/formdef14a.htm
What are Nephros Inc's Past Insider Trades?
Nephros Inc's most recent insider trade came on August 23, 2021 by Wesley Lobo Pursuant To Power of Attorney Previously Filed. who bought 1,000 units worth $7.92K . In the last 12 years, insiders at Nephros Inc have sold an estimated value of $1.05M and bought an estimated value of $2.04M worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Daron Evans, CEO Specialty Renal Product, Andrew Astor, President, and Arthur H Amron, Director .
NEPHROS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||